Michael Unger
Psychiatry · Marietta, GANPI 1316995608
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $27,053 of the $35,335 with a category attached, or 76.6%. 18 manufacturers reported payments, led by Otsuka America Pharmaceutical, Inc. at 43.5% of the total. Reporting peaked in 2019 at $32,511 and has fallen 99.3% since, to $228 in 2025. Among psychiatry clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 193 payments — averaging $183.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$15K
- Sunovion Pharmaceuticals Inc.$14K
- Johnson & Johnson$4K
- Teva Pharmaceuticals USA, Inc.$390
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$377
- AbbVie$371
- plus $939 from 12 others
What the payments were for
- Speaking & faculty fees$27,05377%
- Travel & lodging$4,68013%
- Food & beverage$3,44910%
- Education$1540%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 34 | $15,386 |
| Sunovion Pharmaceuticals Inc. | 17 | $14,236 |
| Johnson & Johnson | 23 | $3,636 |
| Teva Pharmaceuticals USA, Inc. | 19 | $390 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 18 | $377 |
| AbbVie(2 entities) | 35 | $371 |
| Indivior Inc. | 9 | $201 |
| Noven Therapeutics, LLC | 10 | $170 |
| Alkermes, Inc. | 7 | $142 |
| Axsome Therapeutics, Inc. | 5 | $90 |
| Vanda Pharmaceuticals Inc. | 3 | $85 |
| Supernus Pharmaceuticals, Inc. | 4 | $73 |
| Neurocrine Biosciences, Inc. | 3 | $56 |
| Almatica Pharma LLC | 2 | $48 |
| Boston Scientific | 1 | $21 |
| Tris Pharma Inc | 1 | $20 |
| E.r. Squibb & Sons, L.L.C. | 1 | $17 |
| Noven Pharmaceuticals, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ABILIFY MAINTENA$14,781
- LATUDA$14,148
- SPRAVATO$3,185
How this compares
$35,335 in reported general payments places this provider in the 95th percentile of 900 psychiatry providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Quetiapine Fumarate | 36 | $907 |
| Bupropion Hcl SrBupropion Hcl | 21 | $806 |
| Bupropion XlBupropion Hcl | 21 | $720 |
| Olanzapine | 30 | $544 |
| Lurasidone Hcl | 13 | $538 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 28 | $273 |
| Clonazepam | 33 | $249 |
| Fluoxetine Hcl | 17 | $235 |
| Escitalopram Oxalate | 11 | $187 |
| Propranolol Hcl | 11 | $172 |
| Lorazepam | 17 | $127 |
| Alprazolam | 24 | $116 |
| Buspirone Hcl | 11 | $111 |
| Lamotrigine | 12 | $51 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Marietta
- Michael BanovMarietta$733K
- Amy HollandMarietta$17K
- Richard PettyLoganville$2.9M
- Ann GrooverCalhoun$1.4M
- Todd AntinDecatur$1M
- Ben HunterBrookhaven$499K
- Joel MorganValdosta$337K
- Munjal ShroffSmyrna$316K
- David PurselleAtlanta$307K
- Jose CangianoAthens$244K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.